Caption Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-38,500
| Closed | -$285K | – | 816 |
|
|
2024
Q4 | $285K | Buy |
+38,500
| New | +$285K | ﹤0.01% | 353 |
|
|
2024
Q3 | – | Sell |
-30
| Closed | -$241 | – | 659 |
|
|
2024
Q2 | $241 | Sell |
30
-23,692
| -100% | -$190K | ﹤0.01% | 390 |
|
|
2024
Q1 | $352K | Buy |
+23,722
| New | +$352K | 0.01% | 238 |
|
|
2023
Q4 | – | Sell |
-390,000
| Closed | -$1.77M | – | 676 |
|
|
2023
Q3 | $1.77M | Buy |
390,000
+382,200
| +4,900% | +$1.74M | 0.03% | 100 |
|
|
2023
Q2 | $54.9K | Hold |
7,800
| – | – | ﹤0.01% | 297 |
|
|
2023
Q1 | $47.7K | Buy |
+7,800
| New | +$47.7K | ﹤0.01% | 299 |
|
|
2022
Q4 | – | Sell |
-5,397
| Closed | -$52K | – | 644 |
|
|
2022
Q3 | $52K | Sell |
5,397
-32,003
| -86% | -$308K | ﹤0.01% | 439 |
|
|
2022
Q2 | $413K | Buy |
+37,400
| New | +$413K | 0.01% | 285 |
|
|
2022
Q1 | – | Sell |
-70,625
| Closed | -$1.35M | – | 747 |
|
|
2021
Q4 | $1.35M | Buy |
70,625
+41,118
| +139% | +$785K | 0.02% | 223 |
|
|
2021
Q3 | $728K | Sell |
29,507
-18,493
| -39% | -$456K | 0.01% | 300 |
|
|
2021
Q2 | $1.25M | Buy |
+48,000
| New | +$1.25M | 0.02% | 160 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 580 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 488 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 498 |
|
|
2020
Q2 | – | Sell |
-145,200
| Closed | -$4.35M | – | 471 |
|
|
2020
Q1 | $4.35M | Buy |
145,200
+143,600
| +8,975% | +$4.3M | 0.25% | 14 |
|
|
2019
Q4 | $44K | Sell |
1,600
-39,200
| -96% | -$1.08M | ﹤0.01% | 273 |
|
|
2019
Q3 | $743K | Sell |
40,800
-78,800
| -66% | -$1.44M | 0.04% | 110 |
|
|
2019
Q2 | $2.93M | Buy |
+119,600
| New | +$2.93M | 0.15% | 26 |
|